Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study
2020 ◽
2006 ◽
Vol 23
(7)
◽
pp. 768-774
◽
2020 ◽
2020 ◽
2020 ◽
2012 ◽
Vol 97
(10)
◽
pp. 3751-3758
◽
Keyword(s):